Early research (Phase 1)Study completedNCT00739453What this trial is testingDose-escalation Study of OSI-906 and Erlotinib (Tarceva®)Who this might be right forAdvanced Solid Tumors Astellas Pharma Inc 95
Not applicableStudy completedNCT02033343What this trial is testingFeasibility Study Into Adjustment of the Radiation Beam to Account for Prostate Motion During Radiotherapy.Who this might be right forProstate Cancer Royal North Shore Hospital 30
Not applicableWithdrawnNCT03935308What this trial is testingPhase I Study MR-guided SBRT to PCaWho this might be right forLow or Intermediate Risk Prostate Cancer Henry Ford Health System
Testing effectiveness (Phase 2)Study completedNCT00140348What this trial is testingDose Escalation and Efficacy Trial of GVAX® Prostate Cancer VaccineWho this might be right forProstate Cancer Cell Genesys 80
Not applicableStudy completedNCT00416390What this trial is testingLycopene in Treating Patients With Prostate Cancer or Benign Prostatic HyperplasiaWho this might be right forNonmalignant NeoplasmProstate Cancer University of Illinois at Chicago 120
Testing effectiveness (Phase 2)Ended earlyNCT00906243What this trial is testingRNActive®-Derived Therapeutic VaccineWho this might be right forHormone Refractory Prostate Cancer University of Florida 6
Early research (Phase 1)Active Not RecruitingNCT06379217What this trial is testingNEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer.Who this might be right forMetastatic Neuroendocrine Prostate Cancer Novartis Pharmaceuticals 28
Early research (Phase 1)Study completedNCT03388619What this trial is testingHighly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy RadiotherapyWho this might be right forCancer Of ProstateProstate NeoplasmsProstate Cancer+2 more National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Ended earlyNCT01928485What this trial is testingGreen Tea Extract in Treating Patients With Low-Risk Prostate CancerWho this might be right forStage I Prostate CancerStage IIA Prostate CancerStage IIB Prostate Cancer Sanjay Gupta PhD 6
Not applicableStudy completedNCT06016725What this trial is testingOnline Dietary and Resistance Training to Improve Physical Function in Older Cancer Survivors, E-PROOF TrialWho this might be right forAnatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+6 more Ohio State University Comprehensive Cancer Center 75
Testing effectiveness (Phase 2)Study completedNCT00129025What this trial is testingHypofractionated Radiotherapy (55 Gy/16 Fractions/4 Weeks) for Localized Prostate CancerWho this might be right forProstate Cancer Alberta Health services 35
Not applicableStudy completedNCT00002520What this trial is testingPhysician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage CancerWho this might be right forBladder CancerBreast CancerColorectal Cancer+7 more Eastern Cooperative Oncology Group 434
Early research (Phase 1)Study completedNCT01522820What this trial is testingVaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid TumorsWho this might be right forAnaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+62 more Roswell Park Cancer Institute 18
Testing effectiveness (Phase 2)Ended earlyNCT01126879What this trial is testingGenistein in Treating Patients With Prostate CancerWho this might be right forAdenocarcinoma of the ProstateRecurrent Prostate CancerStage I Prostate Cancer+2 more Northwestern University 12
Early research (Phase 1)Study completedNCT02472275What this trial is testingPLX3397, Radiation Therapy, and Antihormone Therapy in Treating Patients With Intermediate- or High-Risk Prostate CancerWho this might be right forStage I Prostate AdenocarcinomaStage II Prostate AdenocarcinomaStage III Prostate Adenocarcinoma Barbara Ann Karmanos Cancer Institute 8
Testing effectiveness (Phase 2)Study completedNCT06472531What this trial is testingPET/CT Imaging Using INR101 Injection in Healthy Male Subjects and Patients With Suspected Prostate CancerWho this might be right forHealthy Male SubjectsSuspected Prostate Cancer Yunhe Pharmaceutical (Tianjin) Co., Ltd 32
Testing effectiveness (Phase 2)Study completedNCT00283829What this trial is testingImmunotherapy After Chemotherapy for Patients With Hormone Refractory Metastatic Prostate CancerWho this might be right forProstate Cancer University of Washington 30
Testing effectiveness (Phase 2)Study completedNCT00414388What this trial is testingSorafenib to Overcome Resistance to Systemic Chemotherapy in Androgen-independent Prostate CancerWho this might be right forProstate Cancer Oncology Specialists, S.C. 22
Not applicableStudy completedNCT00303654What this trial is testingLoop Resectoscope in Treating Patients With Bladder Cancer or Benign Prostatic Hyperplasia Who Are Undergoing Transurethral ResectionWho this might be right forBladder Cancer Roei Medical Technologies Ltd. 24
Early research (Phase 1)UnknownNCT02976402What this trial is testingStereotactic Hypofractionated Accelerated Radiotherapy Post-ProstatectomyWho this might be right forProstate Cancer AdenocarcinomaAdjuvant RadiotherapySalvage Radiotherapy+3 more Fundacao Champalimaud 30